Abstracts

When submitting your abstract please follow these abstract submission instructions.

• All papers must be original and not simultaneously submitted to another journal or conference
• The abstract must
  • be written in scientific English
  • have a maximum length of 2000 characters (including spaces)
  • have a short informative title containing the major keywords (max 200 characters including spaces). The title should not contain abbreviations
  • be a single paragraph without any heading
• Minimize the use of abbreviations, and do not cite references in the abstract
• The author's institutional affiliations must not be included in the abstract to ensure anonymity of the process
• Submitters will be asked to choose either Oral/Poster or Poster only for their abstract. The use of Oral/Poster is encouraged to maximise the abstracts being considered for the oral sessions.
• All accepted abstracts will be published in the HLA journal, and available online. By submitting your abstract, you consent to give EFI permission to publish it.

The following submission categories are available. Submitters are asked to select one primary category that best aligns with their abstract content and, if applicable, a secondary category.  

• Bioinformatics, Artificial Intelligence
• Cancer Immunogenetics
• Haematopoietic Stem Cell Transplantation
• HLA antigen processing and presentation
• Immunogenetics and Infections
• Immunological Tolerance
• Immunotherapy & Gene Therapy
• MHC Evolution, Anthropology & Population Genetics
• New Technologies, Various
• NK cells and KIR
• Reproductive Immunity
• Solid Organ Transplantation
• Other

All the abstracts will be peer-reviewed by the EFI Scientific committee. The authors will receive notification of the decision. Authors selected for presentation (oral communication or poster) will be required to register for the conference.

Local Organizing Committee Chairs

Dr David Turner and Dr Ann-Margaret Little (Edinburgh H&I and Glasgow H&I, Scotland, UK)

Scientific Committee

• Luca Vago - Italy (Chair)
• John Trowsdale - UK
• Alicia Sanchez-Mazas - Switzerland ­­­
• Raphael Carapito - France
• Pietro Crivello - Germany
• Eric Spierings - The Netherlands
• Gonca Karahan - The Netherlands
• Natasja de Groot - The Netherlands
• Jonathan Lucas - UK
• Stefan Schaub - Switzerland

All questions regarding submissions modalities should be emailed to Dr David Turner